Your browser doesn't support javascript.
loading
Ex-vivo activation of a liposomal prodrug of mitomycin C by human tumors.
Dorot, Shira; Tankel, James; Doviner, Victoria; Shmeeda, Hilary; Amitay, Yasmine; Ohana, Patricia; Dagan, Amir; Ben-Haim, Menachem; Reissman, Petachia; Gabizon, Alberto.
Afiliación
  • Dorot S; Department of Surgery, Shaare Zedek Medical Center and Hebrew University-Faculty of Medicine, Jerusalem, Israel.
  • Tankel J; Department of Surgery, Shaare Zedek Medical Center and Hebrew University-Faculty of Medicine, Jerusalem, Israel.
  • Doviner V; Department of Pathology, Shaare Zedek Medical Center and Hebrew University-Faculty of Medicine, Jerusalem, Israel.
  • Shmeeda H; Oncology Institute, Shaare Zedek Medical Center and Hebrew University-Faculty of Medicine, Jerusalem, Israel.
  • Amitay Y; Lipomedix Pharmaceuticals Ltd., Jerusalem, Israel.
  • Ohana P; Lipomedix Pharmaceuticals Ltd., Jerusalem, Israel.
  • Dagan A; Department of Surgery, Shaare Zedek Medical Center and Hebrew University-Faculty of Medicine, Jerusalem, Israel.
  • Ben-Haim M; Department of Surgery, Shaare Zedek Medical Center and Hebrew University-Faculty of Medicine, Jerusalem, Israel.
  • Reissman P; Department of Surgery, Shaare Zedek Medical Center and Hebrew University-Faculty of Medicine, Jerusalem, Israel.
  • Gabizon A; Oncology Institute, Shaare Zedek Medical Center and Hebrew University-Faculty of Medicine, Jerusalem, Israel. alberto.gabizon@gmail.com.
Cancer Chemother Pharmacol ; 90(2): 109-114, 2022 08.
Article en En | MEDLINE | ID: mdl-35802145

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Profármacos / Mitomicina Límite: Animals / Humans Idioma: En Revista: Cancer Chemother Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Profármacos / Mitomicina Límite: Animals / Humans Idioma: En Revista: Cancer Chemother Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Israel